TITAN PHARMACEUTICALS INC — Director's Dealing 2006

Jan 5, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (AMEX-TTP)
CIK: 0000910267
Period of Report: 2006-01-03

Reporting Person: SMITH LEY S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-01-03	Option to Purchase Common Stock	$1.40	A	5000	Acquired	2016-01-03	Common Stock (5000)	Direct

Footnotes

F1: Options to purchase 50% of the shares vest on the first anniversary of the date such options were granted and the remaining
options to purchase 50% of the shares vest in twelve equal monthly installments beginning on February 3, 2007.